IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q4 2013 Holdings

Filed 2014-02-14 | 3 holdings | $157.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synta Pharmaceuticals CorpCOM87162T206$150.1K28,641,84995.3%
Celator Pharmaceuticals IncCOM15089R102$7.3K2,246,4694.6%
Hallmark Finl Svcs Inc ECCOM NEW40624Q203$11913,4450.1%